List of Tables
Table 1. Next Generation Diabetes Therapy and Drug Delivery Market Trends
Table 2. Next Generation Diabetes Therapy and Drug Delivery Market Drivers & Opportunity
Table 3. Next Generation Diabetes Therapy and Drug Delivery Market Challenges
Table 4. Next Generation Diabetes Therapy and Drug Delivery Market Restraints
Table 5. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Next Generation Diabetes Therapy and Drug Delivery Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Next Generation Diabetes Therapy and Drug Delivery Product Type
Table 9. Key Companies Time to Begin Mass Production of Next Generation Diabetes Therapy and Drug Delivery
Table 10. Global Next Generation Diabetes Therapy and Drug Delivery Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Next Generation Diabetes Therapy and Drug Delivery Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Next Generation Diabetes Therapy and Drug Delivery Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Next Generation Diabetes Therapy and Drug Delivery Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Next Generation Diabetes Therapy and Drug Delivery Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value by Region (2019-2024) & (%)
Table 27. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Next Generation Diabetes Therapy and Drug Delivery Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Next Generation Diabetes Therapy and Drug Delivery Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Next Generation Diabetes Therapy and Drug Delivery Sales Value, (2025-2030) & (US$ Million)
Table 31. Johnson & Johnson Basic Information List
Table 32. Johnson & Johnson Description and Business Overview
Table 33. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 34. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Johnson & Johnson (2019-2024)
Table 35. Johnson & Johnson Recent Developments
Table 36. Abbott Laboratories Basic Information List
Table 37. Abbott Laboratories Description and Business Overview
Table 38. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 39. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Abbott Laboratories (2019-2024)
Table 40. Abbott Laboratories Recent Developments
Table 41. Medtronic Basic Information List
Table 42. Medtronic Description and Business Overview
Table 43. Medtronic Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 44. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Medtronic (2019-2024)
Table 45. Medtronic Recent Developments
Table 46. Sanofi Basic Information List
Table 47. Sanofi Description and Business Overview
Table 48. Sanofi Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 49. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Sanofi (2019-2024)
Table 50. Sanofi Recent Developments
Table 51. Novo Nordisk Basic Information List
Table 52. Novo Nordisk Description and Business Overview
Table 53. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 54. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Novo Nordisk (2019-2024)
Table 55. Novo Nordisk Recent Developments
Table 56. MannKind Corporation Basic Information List
Table 57. MannKind Corporation Description and Business Overview
Table 58. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 59. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of MannKind Corporation (2019-2024)
Table 60. MannKind Corporation Recent Developments
Table 61. Enteris BioPharma Basic Information List
Table 62. Enteris BioPharma Description and Business Overview
Table 63. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 64. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Enteris BioPharma (2019-2024)
Table 65. Enteris BioPharma Recent Developments
Table 66. Dexcom Basic Information List
Table 67. Dexcom Description and Business Overview
Table 68. Dexcom Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 69. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Dexcom (2019-2024)
Table 70. Dexcom Recent Developments
Table 71. Senseonics Basic Information List
Table 72. Senseonics Description and Business Overview
Table 73. Senseonics Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 74. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Senseonics (2019-2024)
Table 75. Senseonics Recent Developments
Table 76. Medtech Basic Information List
Table 77. Medtech Description and Business Overview
Table 78. Medtech Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 79. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Medtech (2019-2024)
Table 80. Medtech Recent Developments
Table 81. Synertech Basic Information List
Table 82. Synertech Description and Business Overview
Table 83. Synertech Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 84. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Synertech (2019-2024)
Table 85. Synertech Recent Developments
Table 86. Zosano Pharma Basic Information List
Table 87. Zosano Pharma Description and Business Overview
Table 88. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 89. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Zosano Pharma (2019-2024)
Table 90. Zosano Pharma Recent Developments
Table 91. Relmada Therapeutics Basic Information List
Table 92. Relmada Therapeutics Description and Business Overview
Table 93. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 94. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Relmada Therapeutics (2019-2024)
Table 95. Relmada Therapeutics Recent Developments
Table 96. Eli Lilly and Company Basic Information List
Table 97. Eli Lilly and Company Description and Business Overview
Table 98. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 99. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Eli Lilly and Company (2019-2024)
Table 100. Eli Lilly and Company Recent Developments
Table 101. Transdermal Specialties Basic Information List
Table 102. Transdermal Specialties Description and Business Overview
Table 103. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Products, Services and Solutions
Table 104. Revenue (US$ Million) in Next Generation Diabetes Therapy and Drug Delivery Business of Transdermal Specialties (2019-2024)
Table 105. Transdermal Specialties Recent Developments
Table 106. Key Raw Materials Lists
Table 107. Raw Materials Key Suppliers Lists
Table 108. Next Generation Diabetes Therapy and Drug Delivery Downstream Customers
Table 109. Next Generation Diabetes Therapy and Drug Delivery Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Next Generation Diabetes Therapy and Drug Delivery Product Picture
Figure 2. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value (2019-2030) & (US$ Million)
Figure 4. Next Generation Diabetes Therapy and Drug Delivery Report Years Considered
Figure 5. Global Next Generation Diabetes Therapy and Drug Delivery Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2023
Figure 7. Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Inhalable Insulin Picture
Figure 9. Oral Insulin Picture
Figure 10. Insulin Patches Picture
Figure 11. CGM Systems Picture
Figure 12. Artificial Pancreas Picture
Figure 13. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Diagnostic/Clinics
Figure 16. Product Picture of ICUs
Figure 17. Product Picture of Home Healthcare
Figure 18. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Next Generation Diabetes Therapy and Drug Delivery Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Next Generation Diabetes Therapy and Drug Delivery Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Next Generation Diabetes Therapy and Drug Delivery Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Next Generation Diabetes Therapy and Drug Delivery Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Next Generation Diabetes Therapy and Drug Delivery Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Next Generation Diabetes Therapy and Drug Delivery Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Next Generation Diabetes Therapy and Drug Delivery Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Next Generation Diabetes Therapy and Drug Delivery Sales Value (%), (2019-2030)
Figure 31. United States Next Generation Diabetes Therapy and Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Next Generation Diabetes Therapy and Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Next Generation Diabetes Therapy and Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Next Generation Diabetes Therapy and Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Next Generation Diabetes Therapy and Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Next Generation Diabetes Therapy and Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 37. China Next Generation Diabetes Therapy and Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Next Generation Diabetes Therapy and Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 39. China Next Generation Diabetes Therapy and Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Next Generation Diabetes Therapy and Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Next Generation Diabetes Therapy and Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Next Generation Diabetes Therapy and Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Next Generation Diabetes Therapy and Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Next Generation Diabetes Therapy and Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Next Generation Diabetes Therapy and Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 49. India Next Generation Diabetes Therapy and Drug Delivery Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Next Generation Diabetes Therapy and Drug Delivery Sales Value by Type (%), 2023 VS 2030
Figure 51. India Next Generation Diabetes Therapy and Drug Delivery Sales Value by Application (%), 2023 VS 2030
Figure 52. Next Generation Diabetes Therapy and Drug Delivery Industrial Chain
Figure 53. Next Generation Diabetes Therapy and Drug Delivery Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
